Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

New guidelines and referral pathways for skin conditions aim to improve care and referrals in Pakistan.

FUT is a hair restoration method that should be chosen based on individual patient needs and preferences.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Testosterone therapy is effective and safe for women with low sexual desire, but it's hard to access.

Androgenic alopecia is diagnosed by clinical evaluation and managed with treatments to stop hair loss and encourage regrowth.

Androgenic alopecia is diagnosed by clinical evaluation and managed with treatments to stop hair loss and encourage regrowth.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

The guidelines help doctors diagnose and treat hormone-related disorders in women.

Treat significant hirsutism with medication and hair removal; use birth control pills first, adding antiandrogens if needed.

Current guidelines may overlook beard and sideburn involvement in diagnosing frontal fibrosing alopecia in men.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Guidelines help safely perform cosmetic procedures on vitiligo patients to avoid new skin lesions.

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Treat androgenetic alopecia early with recommended medications or consider hair grafts and wigs if unresponsive.

Nurse Practitioners play a key role in managing PCOS despite lacking specific guidelines.